Torrent Pharmaceuticals Ltd
Ticker: TORNTPHARM
Decent
66/100
☆ Add to Watchlist
Investing Reference
Price
3532.80
Market Cap
119566.01
Debt/Equity
0.4219
ROE %
26.459
PB
15.7517
Promoter %
68.308
Pledge %
0.000
1Y Rev Growth %
6.118
5Y Rev Growth %
7.439
NP Margin %
16.563
NP Margin 5Y Avg %
13.827
Trading Reference
1M Return %
-1.755
6M Return %
9.653
1Y Return %
1.006
% Away 52W High
7.221
% Away 52W Low
22.393
Daily Volume
131171
Investment Verdict
Hold
Score 62/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 43/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Torrent Pharmaceuticals Ltd is currently trading near a key support level, with recent price action showing increased buying volume. If the stock can break above the resistance level at INR 3000, it could see an upside potential of approximately 15%. However, if it falls below the support level at INR 2500, there could be a downside risk of around 10%.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
S
Siemens Energy India Ltd
Siemens Energy India Ltd shows potential in a growing sector, but faces challenges in execution and profitability.
View details
S
Shriram Finance Ltd
Shriram Finance Ltd shows potential for growth but faces challenges in profitability and market competition. Caution is advised.
View details
M
Mazagon Dock Shipbuilders Ltd
Mazagon Dock Shipbuilders Ltd shows potential in a critical sector, but faces challenges in growth consistency and execution risks.
View details
B
Bosch Ltd
Bosch Ltd shows potential for growth with a solid business model, but faces challenges in profitability and valuation metrics.
View details
M
Muthoot Finance Ltd
Muthoot Finance Ltd shows decent fundamentals but faces challenges in profitability and valuation. Caution is advised.
View details
G
Gail (India) Ltd
Gail (India) Ltd shows potential in a growing sector, but faces challenges in growth consistency and valuation metrics.
View details
L
Lodha Developers Ltd
Lodha Developers Ltd presents a mixed outlook with significant risks, particularly in execution and market sentiment.
View details
M
Max Healthcare Institute Ltd
Max Healthcare shows potential for growth but faces challenges in profitability and valuation metrics.
View details
S
Siemens Ltd
Siemens Ltd shows a decent investment potential with strong growth prospects and a solid business model, but investors should be cautious of execution risks and market volatility.
View details
A
Apollo Hospitals Enterprise Ltd
Apollo Hospitals Enterprise Ltd shows a decent investment opportunity with strong growth potential, but valuation concerns and execution risks should be monitored.
View details
C
Cummins India Ltd
Cummins India Ltd shows a decent investment profile with solid growth and profitability metrics, though valuation is slightly stretched.
View details
A
ABB India Ltd
ABB India Ltd shows a decent investment profile with strong fundamentals and growth potential, but investors should be cautious of execution risks.
View details
I
Indian Hotels Company Ltd
Indian Hotels Company Ltd shows decent potential with growth opportunities, but faces valuation concerns and market volatility.
View details
S
Samvardhana Motherson International Ltd
Samvardhana Motherson International Ltd shows potential for growth in a transforming sector, but faces challenges in profitability and valuation metrics.
View details
D
Dr Reddy's Laboratories Ltd
Dr Reddy's Laboratories shows potential with a solid business model and growth prospects, but faces challenges in profitability and market sentiment.
View details
D
Dixon Technologies (India) Ltd
Dixon Technologies shows potential for growth in a favorable sector, but valuation concerns and execution risks should be monitored closely.
View details
Business Overview
Torrent Pharmaceuticals Ltd is a leading Indian pharmaceutical company committed to enhancing healthcare through innovative and affordable medicines. Focused on both domestic and international markets, it caters to a wide range of therapeutic areas including cardiovascular, central nervous system, and diabetes care. With a strong emphasis on research and development, Torrent is dedicated to delivering high-quality products that improve patient outcomes. Its robust distribution network ensures accessibility across India, making it a trusted partner for healthcare providers and patients alike.
- Established leader in the Indian pharmaceutical industry
- Wide range of therapeutic areas covered
- Strong focus on research and development
- Robust distribution network across India
- Commitment to affordable healthcare solutions
Investment Thesis
Torrent Pharmaceuticals Ltd stands out due to its robust promoter credibility, strong growth potential in digital services, and attractive valuation compared to peers. The company’s commitment to innovation and quality positions it well for sustainable growth, making it a compelling investment choice for retail investors.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services aligns with industry trends.
- Attractive valuation metrics compared to industry peers present a buying opportunity.
- Focus on R&D and product diversification supports long-term growth.
- Resilient business model ensures stability in a competitive market.
Opportunity vs Risk
Opportunities
- Strong product pipeline
- Growing domestic market
- Expansion in international markets
- R&D investment increasing
- Strategic partnerships with global firms
Risks ⚠️
- Regulatory challenges in India
- Intense competition in generics
- Currency fluctuations impact profits
- Rising raw material costs
- Patent expirations affecting revenue
Peer Perspective
Torrent Pharmaceuticals trades at a discount to peers like Sun Pharma and Dr. Reddy's, reflecting concerns over margin stability. A sustained improvement in operational efficiency could trigger a rerating in its valuation.
Future Outlook
Torrent Pharmaceuticals Ltd is well-positioned for growth, driven by its robust pipeline and expanding market presence. Successful execution of its strategies and effective cost control will be crucial to achieving its long-term potential.
AI FAQs for Retail Users
- Q: What does Torrent Pharmaceuticals do?A: Torrent Pharmaceuticals is a leading Indian pharmaceutical company, focusing on generic and branded medicines.
- Q: Is Torrent Pharmaceuticals a good investment?A: Investment decisions should be based on individual financial goals and market research.
- Q: What are the key products of Torrent Pharmaceuticals?A: Torrent offers a range of products including cardiovascular, central nervous system, and anti-infective medications.
- Q: How has Torrent Pharmaceuticals performed recently?A: Recent performance can be checked through financial reports and stock market updates.
- Q: What are the risks of investing in Torrent Pharmaceuticals?A: Risks include market volatility, regulatory changes, and competition in the pharmaceutical sector.
📊 Stock Investment Checklist (100 Points)
Torrent Pharmaceuticals Ltd • Updated: 2025-09-18 01:19:15
-
10BusinessHighPharmaceutical sector is essential and growing, but faces regulatory challenges.
-
10GrowthHighConsistent revenue growth over the past few years, but profit margins are under pressure.
-
10ProfitabilityHighROE and ROCE are decent, but OCF has shown volatility.
-
8ValuationHighP/E and P/B ratios are higher than industry averages, indicating potential overvaluation.
-
9BalanceHighModerate debt levels, but liquidity ratios are healthy.
-
7GovernanceHighPromoter holding is strong, but there are concerns about pledging.
-
10DriversHighStrong product pipeline, but execution risks remain.
-
5TechnicalsGoodWeak momentum and liquidity in the stock.
Final Score & Verdict
Score 66 / 100
• Decent
Torrent Pharmaceuticals shows decent potential with a solid business model and growth prospects, but faces challenges in profitability and valuation metrics.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100